Icon Biopharma And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
- Paid Up Capital ₹ 11.62 Cr
- Company Age 31 Year, 1 Month
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 4.14 Cr
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets %
About Icon Biopharma And Healthcare
Icon Biopharma And Healthcare Limited (IBAHL) is a Public Limited Indian Non-Government Company incorporated in India on 07 January 1994 and has a history of 31 years and one month. Its registered office is in Nagar Highway,Ahmedabad.15, Gujarat.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 11.62 Cr.
The company currently has active open charges totaling ₹4.14 Cr.
Vikeshkumar Patel, Dushyant Patel, and Sureshbhai Patel serve as directors at the Company.
Company Details
-
LocationNagar Highway,Ahmedabad.15, Gujarat
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
L24232GJ1994PLC021023
-
Company No.
021023
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
07 Jan 1994
-
Date of AGM
29 Sep 2018
-
Date of Balance Sheet
31 Mar 2018
-
Listing Status
Listed
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Icon Biopharma And Healthcare?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Vikeshkumar Patel | Additional Director | 05-Aug-2010 | Current |
Dushyant Patel | Additional Director | 05-Aug-2010 | Current |
Sureshbhai Patel | Additional Director | 10-Feb-2012 | Current |
Financial Performance of Icon Biopharma And Healthcare.
Icon Biopharma And Healthcare Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Icon Biopharma And Healthcare?
In 2018, Icon Biopharma And Healthcare had a promoter holding of 66.15% and a public holding of 33.85%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹4.14 Cr
₹0
Charges Breakdown by Lending Institutions
- Gujarat State Financial Corporation : 2.46 Cr
- The Visnagar Nagrik Sahakari Ltd. : 0.77 Cr
- Canara Bank : 0.66 Cr
- Vrashti Finance Services Pvt Ltd. : 0.22 Cr
- Dena Bank : 0.03 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
14 Aug 2000 | Gujarat State Financial Corporation | ₹9.10 M | Open |
02 May 2000 | Dena Bank | ₹0.28 M | Open |
24 Sep 1999 | Gujarat State Financial Corporation | ₹1.30 Cr | Open |
19 Feb 1997 | The Visnagar Nagrik Sahakari Ltd. | ₹7.70 M | Open |
18 Jun 1996 | Vrashti Finance Services Pvt Ltd. | ₹2.20 M | Open |
How Many Employees Work at Icon Biopharma And Healthcare?
Unlock and access historical data on people associated with Icon Biopharma And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icon Biopharma And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icon Biopharma And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.